Several senior officials are exiting RFK Jr.'s department amid an effort to focus on drug pricing and food issues.

The FDA has rejected a rare disease therapy from Disc Medicine, an early recipient of a commissioner's voucher from the ...

The FDA’s surprise refusal to even review Moderna’s mRNA flu vaccine is sending a chill through biotech: Companies are openly ...

After a day of oral arguments in a packed courtroom, a Boston federal judge did not rule from the bench on a lawsuit from AAP against HHS focused on vaccines.

Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug ahead of an expected decision by the U.S. Food and Drug Administration in April, Reuters writes, ...

That surveillance data was the nervous system of American medicine — constantly sensing, constantly warning us what was ...

In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well ...

This week on "The Readout LOUD," everything you need to know about the FDA's controversial decision to block the review of ...

Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.

Kennedy Jr. upends so much of the nation’s health care system, the once-unthinkable has often come to be accepted as the new normal. Perhaps one of the most startling realities is this: The American ...

A group of European venture capital firms is banding together to try to improve the funding landscape for biotech startups.

Executives at large vaccine developers have dealt with tremendous uncertainty as health secretary and longtime vaccine critic Robert F. Kennedy Jr. has removed shots from the childhood vaccination ...